FIELD: medicine, pharmacology, pharmaceutical technology, pharmacy.
SUBSTANCE: invention relates to a new generation of antibacterial preparations based on D-cycloserine that comprises nanoparticles and possessing the regulated effect. Method for preparing this preparation involves heating an agent containing a mixture consisting of D-cycloserine, PLGA 50/50, D-mannitol, polysorbate-80 and dimethylsulfoxide taken in the definite ratio at temperature 50-60oC to obtain uniform clear liquid followed by its cooling to room temperature, dilution with water, and formed suspension containing nanoparticles of size 3.0 ± 0.5 nM (˜20% of the total amount of particles) and ˜200 nM (˜80% of the total amount of particles) are used by designation. Invention provides preparing the preparation possessing high antibacterial activity, prolonged effect, relative harmless and low toxicity.
EFFECT: improved preparing method, improved and valuable medicinal properties of agent.
3 cl, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICINAL AGENT BASED ON RYBAFUTIN, AGENT OF ANTIMICROBIC ACTION CONTAINING NANOPARTICLES, AND RELATED METHOD OF PRODUCTION | 2007 |
|
RU2327457C1 |
ANTIMICROBIAL MEDICINAL AGENT, METHOD OF PRODUCTION OF DIRECTIONAL MEDICINAL AGENT CONTAINIG NANOPARTICLES | 2007 |
|
RU2327459C1 |
DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
ANTIBACTERIAL AGENT FOR TREATMENT OF INTRACELLULAR INFECTION | 2006 |
|
RU2308970C1 |
AGENT FOR BACTERIAL INFECTIONS TREATMENT | 2007 |
|
RU2337711C1 |
RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
ANTI-TUMOUR PREPARATION | 2011 |
|
RU2451509C1 |
ANTICANCER DRUG BASED ON NICLOSAMIDE | 2016 |
|
RU2617049C1 |
METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
Authors
Dates
2008-03-10—Published
2007-04-10—Filed